During the past decade, IMMUNOe Research Centers conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 26 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IMMUNOe Research Centers" #1 sponsor was "Shire" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "ADMA Biologics, Inc." with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IMMUNOe Research Centers" #1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Bio Products Laboratory" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "IMMUNOe Research Centers" are "Asthma" (9 trials), "Atopic Dermatitis" (4 trials), "Autism" (3 trials), "Alzheimer's Disease" (2 trials) and "Common Variable Immunodeficiency" (2 trials). Many other conditions were trialed in "IMMUNOe Research Centers" in a lesser frequency.

Most popular intervention types in "IMMUNOe Research Centers" are "Drug" (38 trials), "Biological" (18 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Lebrikizumab" (5 trials), "Bivigam" (2 trials), "CM-AT" (2 trials) and "Matching Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "IMMUNOe Research Centers" are 53 trials for "All" genders.

Currently, there are NaN active trials in "IMMUNOe Research Centers". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in IMMUNOe Research Centers, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IMMUNOe Research Centers, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 0 trials that are defined as “Not Applicable".